This session offers pharmacists the opportunity to gain an insight into the management of cancer associated thrombosis (CAT), including recent developments in anticoagulant treatment options, developments in the prevention of CAT, and examples of pharmacist-led CAT pathways

Learning outcomes:

- To understand the prevalence, aetiology and pathophysiology of cancer associated thrombosis (CAT)
- To gain an insight into the treatment and prevention strategies for CAT
- To gain an awareness of pharmacy-led CAT pathways